Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Leroy Hood, Frederick Hawthorne, Susan Evans, Mike Aicher

Premium

US President Barack Obama has named Institute for Systems Biology president Leroy Hood and Frederick Hawthorne, director of the Institute of Nano and Molecular Medicine at the University of Missouri at Columbia, as two of the 12 new winners of its National Medal of Science awards.


Susan Evans has been appointed to Venaxis' board of directors. She is vice president of scientific affairs for Danaher's Beckman Coulter division. She has held various positions at Beckman Coulter, including as vice president of corporate strategic planning, and vice president/general manager of Beckman Coulter Genomics. She holds a PhD in chemistry from the University of Detroit.


Omicia has appointed Mike Aicher to CEO and to the company's board of directors, taking over for Martin Reese, a co-founder of the company. Reese is now Omicia's president and chief scientific officer. Previously, Aicher was CEO of the National Genetics Institute, a company that he co-founded that became a wholly owned subsidiary of Laboratory Corporation of America. Most recently, he led LabCorp's western division and was responsible for the company's esoteric business units. He holds a BS in business administration from the University of Redlands and an MBA in economics from Columbus University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.